da sogar solche 10-Q ber. noch als zukunftsweisend und positiv ausgelegt werden
verlust, Rückgang, undurchsichtige Machenschaften, und bestbezahlte CEO
wie kann man die Firmenwert immer noch auf der gleiche höhe bewerten wie vor ein jahr ( 31M ) ??? schleierhaft für mich ...
www.sec.gov/Archives/edgar/data/806592/...3000064/suwn10-q.htm
seite 19.
Nine months ended January 31, 2013 compared to same period in 2012
Our total revenues in the first nine months of fiscal 2013 decreased by 18.1%, compared with the same period in fiscal 2012, while our gross margin increased to 19.0% from 16.6% over the same period in fiscal 2012. Our operating expenses during the first nine months of fiscal 2013 decreased by 1.7% compared with the same period in fiscal 2012. Our net loss for the first nine months of fiscal 2013 was $3.1 million, compared to a loss of $3.0 million for the same period in fiscal 2012. Stevioside revenues, which comprised 67.7% and 74.1 % of our revenues for the first nine months of fiscal 2013 and fiscal 2012, respectively, decreased by $1.7 million, or 25.2%, while Chinese Medicine revenues increased by $0.1 million, or 2.2%.
Our operating performance in the first nine months of fiscal 2013 was driven by the sales return of $0.3 million for lower grades stevia products in our Stevioside segment. In addition, the demand growth for our intermediate and higher grade stevia products was slower than anticipated in international markets, especially the North America market, was behind expectations as the demand is relatively smaller than the supply. We also continue to experience significant downward pressure on pricing for some of our products as some of our smaller competitors have been required to liquidate their inventory while under financial distress. We produced 168.0 metric tons of Stevioside for the first nine months of fiscal 2013 as compared to 266.3 metric tons during the same period in fiscal 2012
oder habt ihr Tomaten auf der Augen ?